Arshad Khan, PhD, earned his bachelor's in biochemistry and a graduate degree in molecular and medical pharmacology, both from UCLA. He is a pharmaceutical and biotechnology research professional with 21 years of molecular biology experience. His work at UCLA primarily focused on molecular biology and genetics disciplines. His previous work focused on various neurological and behavioral disorders, (e.g., Parkinson's, Alzheimer's, cocaine addiction and others). His expertise in genetics and computational biology helped him to discover genes that are associated with Parkinson's, Alzheimer's and other neurological disorders, as well as drug actions on genes for cell survival. He is currently a bioinformatic biomedical scientist at Cedars-Sinai and leads all bioinformatics analysis support for omics datasets, particularly the integration of omics datasets (transcriptomic datasets from either bulk or single-cell seq methodologies) of inflammatory bowel disease patients using QTL methods to discover key genes that are associated with inflammatory bowel diseases.